| ROI Name | ∑ In | % In | log ratio | ∑ Out | % Out |
|---|---|---|---|---|---|
| SLP(L) | 28 | 14.7% | 2.09 | 119 | 50.9% |
| AL(L) | 143 | 74.9% | -5.57 | 3 | 1.3% |
| LH(L) | 9 | 4.7% | 2.64 | 56 | 23.9% |
| CentralBrain-unspecified | 4 | 2.1% | 3.13 | 35 | 15.0% |
| SCL(L) | 1 | 0.5% | 3.32 | 10 | 4.3% |
| CA(L) | 4 | 2.1% | 0.58 | 6 | 2.6% |
| PLP(L) | 2 | 1.0% | 1.32 | 5 | 2.1% |
| SMP(L) | 0 | 0.0% | 0.00 | 0 | 0.0% |
| upstream partner | # | NT | conns CB3383 | % In | CV |
|---|---|---|---|---|---|
| ORN_VL1 | 4 | ACh | 10 | 9.4% | 1.0 |
| v2LN30 (L) | 1 | unc | 7 | 6.6% | 0.0 |
| v2LN32 (L) | 1 | Glu | 6 | 5.7% | 0.0 |
| M_vPNml53 (L) | 2 | GABA | 5 | 4.7% | 0.6 |
| M_lvPNm37 (L) | 2 | ACh | 5 | 4.7% | 0.6 |
| M_l2PNm15 (L) | 1 | ACh | 4 | 3.8% | 0.0 |
| CB2208 (L) | 1 | ACh | 4 | 3.8% | 0.0 |
| LHAD4a1 (L) | 1 | Glu | 4 | 3.8% | 0.0 |
| M_l2PNm16 (L) | 2 | ACh | 4 | 3.8% | 0.5 |
| CB3417 (L) | 2 | unc | 4 | 3.8% | 0.0 |
| OA-VUMa2 (M) | 1 | OA | 3 | 2.8% | 0.0 |
| HRN_VP1d | 1 | ACh | 2 | 1.9% | 0.0 |
| LHPV6f3_b (R) | 1 | ACh | 2 | 1.9% | 0.0 |
| CB1246 (L) | 1 | GABA | 2 | 1.9% | 0.0 |
| M_lvPNm35 (L) | 1 | ACh | 2 | 1.9% | 0.0 |
| lLN2P_c (L) | 1 | GABA | 2 | 1.9% | 0.0 |
| lLN2X12 (L) | 1 | ACh | 2 | 1.9% | 0.0 |
| lLN2F_a (L) | 1 | unc | 2 | 1.9% | 0.0 |
| ORN_VM6m | 2 | ACh | 2 | 1.9% | 0.0 |
| v2LN39a (L) | 2 | Glu | 2 | 1.9% | 0.0 |
| lLN2P_a (L) | 2 | GABA | 2 | 1.9% | 0.0 |
| ORN_VM6l | 1 | ACh | 1 | 0.9% | 0.0 |
| HRN_VP1l | 1 | ACh | 1 | 0.9% | 0.0 |
| v2LNX01 (L) | 1 | unc | 1 | 0.9% | 0.0 |
| LHPV6f3_b (L) | 1 | ACh | 1 | 0.9% | 0.0 |
| v2LN5 (L) | 1 | ACh | 1 | 0.9% | 0.0 |
| ORN_VL2a | 1 | ACh | 1 | 0.9% | 0.0 |
| FS4B (R) | 1 | ACh | 1 | 0.9% | 0.0 |
| ORN_VM6v | 1 | ACh | 1 | 0.9% | 0.0 |
| CB1059 (L) | 1 | Glu | 1 | 0.9% | 0.0 |
| HRN_VP4 | 1 | ACh | 1 | 0.9% | 0.0 |
| SLP403 (R) | 1 | unc | 1 | 0.9% | 0.0 |
| CB1296_a (L) | 1 | GABA | 1 | 0.9% | 0.0 |
| M_lvPNm38 (L) | 1 | ACh | 1 | 0.9% | 0.0 |
| CB4083 (R) | 1 | Glu | 1 | 0.9% | 0.0 |
| v2LN41 (L) | 1 | unc | 1 | 0.9% | 0.0 |
| CB1551 (L) | 1 | ACh | 1 | 0.9% | 0.0 |
| CB4091 (L) | 1 | Glu | 1 | 0.9% | 0.0 |
| CB2224 (L) | 1 | ACh | 1 | 0.9% | 0.0 |
| VP1m+_lvPN (L) | 1 | Glu | 1 | 0.9% | 0.0 |
| SLP064 (L) | 1 | Glu | 1 | 0.9% | 0.0 |
| CL356 (L) | 1 | ACh | 1 | 0.9% | 0.0 |
| lLN2R_a (L) | 1 | GABA | 1 | 0.9% | 0.0 |
| vLN24 (L) | 1 | ACh | 1 | 0.9% | 0.0 |
| OA-VUMa5 (M) | 1 | OA | 1 | 0.9% | 0.0 |
| lLN2X11 (L) | 1 | ACh | 1 | 0.9% | 0.0 |
| lLN2X05 (L) | 1 | ACh | 1 | 0.9% | 0.0 |
| ALIN5 (R) | 1 | GABA | 1 | 0.9% | 0.0 |
| CSD (R) | 1 | 5-HT | 1 | 0.9% | 0.0 |
| M_l2PNl20 (L) | 1 | ACh | 1 | 0.9% | 0.0 |
| VM6_adPN (L) | 1 | ACh | 1 | 0.9% | 0.0 |
| downstream partner | # | NT | conns CB3383 | % Out | CV |
|---|---|---|---|---|---|
| CB3556 (L) | 3 | ACh | 22 | 7.2% | 0.4 |
| LHPV4b4 (L) | 4 | Glu | 20 | 6.6% | 0.7 |
| M_vPNml53 (L) | 3 | GABA | 17 | 5.6% | 1.2 |
| CB0943 (L) | 3 | ACh | 15 | 4.9% | 0.7 |
| CB3055 (L) | 2 | ACh | 11 | 3.6% | 0.5 |
| CB2208 (L) | 4 | ACh | 10 | 3.3% | 0.4 |
| CB1608 (L) | 1 | Glu | 8 | 2.6% | 0.0 |
| CB1057 (L) | 1 | Glu | 8 | 2.6% | 0.0 |
| SLP266 (L) | 2 | Glu | 8 | 2.6% | 0.5 |
| LHPV5i1 (L) | 1 | ACh | 7 | 2.3% | 0.0 |
| LHPV4b3 (L) | 1 | Glu | 6 | 2.0% | 0.0 |
| SLP078 (L) | 2 | Glu | 6 | 2.0% | 0.7 |
| CB1154 (L) | 2 | Glu | 6 | 2.0% | 0.7 |
| CB2600 (L) | 2 | Glu | 6 | 2.0% | 0.3 |
| CB4122 (L) | 3 | Glu | 6 | 2.0% | 0.4 |
| LHPV5h2_c (L) | 1 | ACh | 5 | 1.6% | 0.0 |
| SMP304 (L) | 1 | GABA | 5 | 1.6% | 0.0 |
| FB1E_b (L) | 1 | Glu | 5 | 1.6% | 0.0 |
| LHAV3k6 (L) | 1 | ACh | 5 | 1.6% | 0.0 |
| CB3081 (L) | 2 | ACh | 5 | 1.6% | 0.6 |
| FB8B (L) | 2 | Glu | 5 | 1.6% | 0.2 |
| LHPV6f3_b (L) | 1 | ACh | 4 | 1.3% | 0.0 |
| LHAD3b1_a (L) | 1 | ACh | 4 | 1.3% | 0.0 |
| FB1E_a (L) | 1 | Glu | 4 | 1.3% | 0.0 |
| SLP249 (L) | 1 | Glu | 4 | 1.3% | 0.0 |
| CB1326 (L) | 2 | ACh | 4 | 1.3% | 0.5 |
| CB1901 (L) | 2 | ACh | 4 | 1.3% | 0.5 |
| LHAV5b2 (L) | 2 | ACh | 4 | 1.3% | 0.5 |
| SLP373 (L) | 1 | unc | 3 | 1.0% | 0.0 |
| CB1011 (L) | 1 | Glu | 3 | 1.0% | 0.0 |
| M_vPNml54 (L) | 1 | GABA | 3 | 1.0% | 0.0 |
| CB4126 (L) | 1 | GABA | 3 | 1.0% | 0.0 |
| LHAV5a1 (L) | 1 | ACh | 3 | 1.0% | 0.0 |
| M_lvPNm38 (L) | 1 | ACh | 3 | 1.0% | 0.0 |
| FB8I (L) | 1 | Glu | 3 | 1.0% | 0.0 |
| CB1104 (L) | 1 | ACh | 3 | 1.0% | 0.0 |
| VM6_lvPN (L) | 2 | ACh | 3 | 1.0% | 0.3 |
| LHPV4b1 (L) | 2 | Glu | 3 | 1.0% | 0.3 |
| VL1_vPN (L) | 1 | GABA | 2 | 0.7% | 0.0 |
| SLP322 (L) | 1 | ACh | 2 | 0.7% | 0.0 |
| SLP164 (L) | 1 | ACh | 2 | 0.7% | 0.0 |
| LHPD3a2_a (L) | 1 | Glu | 2 | 0.7% | 0.0 |
| LHPV4c4 (L) | 1 | Glu | 2 | 0.7% | 0.0 |
| LHPV4c2 (L) | 1 | Glu | 2 | 0.7% | 0.0 |
| M_vPNml73 (L) | 1 | GABA | 2 | 0.7% | 0.0 |
| CL087 (L) | 1 | ACh | 2 | 0.7% | 0.0 |
| M_lvPNm44 (L) | 1 | ACh | 2 | 0.7% | 0.0 |
| FB1D (L) | 1 | Glu | 2 | 0.7% | 0.0 |
| LNd_c (L) | 1 | ACh | 2 | 0.7% | 0.0 |
| LHPV4a10 (L) | 1 | Glu | 2 | 0.7% | 0.0 |
| CB2814 (L) | 2 | Glu | 2 | 0.7% | 0.0 |
| SLP358 (L) | 1 | Glu | 1 | 0.3% | 0.0 |
| LHAV7a1_a (L) | 1 | Glu | 1 | 0.3% | 0.0 |
| CB1617 (L) | 1 | Glu | 1 | 0.3% | 0.0 |
| CB2269 (L) | 1 | Glu | 1 | 0.3% | 0.0 |
| LHPD3a4_b (L) | 1 | Glu | 1 | 0.3% | 0.0 |
| CB4022 (L) | 1 | ACh | 1 | 0.3% | 0.0 |
| DN1pA (L) | 1 | Glu | 1 | 0.3% | 0.0 |
| SMP305 (L) | 1 | unc | 1 | 0.3% | 0.0 |
| LHPD4b1 (L) | 1 | Glu | 1 | 0.3% | 0.0 |
| CB3173 (L) | 1 | ACh | 1 | 0.3% | 0.0 |
| LHPV4c3 (L) | 1 | Glu | 1 | 0.3% | 0.0 |
| LHPV6f3_b (R) | 1 | ACh | 1 | 0.3% | 0.0 |
| SLP038 (L) | 1 | ACh | 1 | 0.3% | 0.0 |
| LHPV6a3 (L) | 1 | ACh | 1 | 0.3% | 0.0 |
| SMP219 (L) | 1 | Glu | 1 | 0.3% | 0.0 |
| M_adPNm5 (L) | 1 | ACh | 1 | 0.3% | 0.0 |
| FB8H (L) | 1 | Glu | 1 | 0.3% | 0.0 |
| CB1059 (L) | 1 | Glu | 1 | 0.3% | 0.0 |
| SLP363 (L) | 1 | Glu | 1 | 0.3% | 0.0 |
| LHPV6f5 (L) | 1 | ACh | 1 | 0.3% | 0.0 |
| LHAV5e1 (L) | 1 | Glu | 1 | 0.3% | 0.0 |
| LHPV4g1 (L) | 1 | Glu | 1 | 0.3% | 0.0 |
| M_lvPNm45 (L) | 1 | ACh | 1 | 0.3% | 0.0 |
| CL234 (L) | 1 | Glu | 1 | 0.3% | 0.0 |
| M_lvPNm37 (L) | 1 | ACh | 1 | 0.3% | 0.0 |
| CSD (L) | 1 | 5-HT | 1 | 0.3% | 0.0 |
| LHPV8a1 (L) | 1 | ACh | 1 | 0.3% | 0.0 |
| M_l2PN3t18 (L) | 1 | ACh | 1 | 0.3% | 0.0 |
| M_l2PNm16 (L) | 1 | ACh | 1 | 0.3% | 0.0 |
| LHPV3c1 (L) | 1 | ACh | 1 | 0.3% | 0.0 |
| VP1d+VP4_l2PN2 (L) | 1 | ACh | 1 | 0.3% | 0.0 |
| CSD (R) | 1 | 5-HT | 1 | 0.3% | 0.0 |
| ALIN6 (R) | 1 | GABA | 1 | 0.3% | 0.0 |
| lLN2F_b (L) | 1 | GABA | 1 | 0.3% | 0.0 |
